Cite

HARVARD Citation

    Pratley, R. et al. (2020). Impact of patient characteristics on efficacy and safety of once-weekly semaglutide versus dulaglutide: SUSTAIN 7 post hoc analyses. BMJ open. 10 (11), p. . [Online]. 
  
Back to record